Objective
The overall objective of the project is to advance knowledge and technologies for modelling intestinal dysbiosis in vitro, in order to provide miniaturised colonic fermentation tools and organ-on-chip systems that enable the assessment or design of prevention and/or therapy strategies aimed at restoring the balance of the microbiota and, therefore, recovering healthy functioning of the body’s physiological conditions. The scope of the project applies to companies in the nutraceutical, food, pharmaceutical and biotechnology sectors.
Activities
- Development of a new miniaturised integrated in vitro model capable of simulating dysbiosis and the intestinal mucosa
- Optimisation of a miniaturised in vitro model capable of simulating the microbiota-gut-brain axis
- Viability and use of faecal microbiota for diagnosis and obtaining bioactive agents
- Coordination and management.
- Technology transfer and promotion of results.
- Dissemination and communication.
Dissemination/Transfer
Press releases
AINIA launches 11 new R&D&I projects with the support of IVACE-FEDER
